Squamous cell carcinoma of pharynx – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Thu, 28 May 2026 11:03:54 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Squamous cell carcinoma of pharynx – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study of low-dose radiation therapy combined with paclitaxel and carboplatin in patients with advanced throat and larynx cancer https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-low-dose-radiochemotherapy-with-carboplatin-and-paclitaxel-for-patients-with-advanced-throat-and-larynx-cancer/ Wed, 29 Apr 2026 15:02:24 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-low-dose-radiochemotherapy-with-carboplatin-and-paclitaxel-for-patients-with-advanced-throat-and-larynx-cancer/ This clinical trial focuses on patients with advanced throat and larynx cancer. The study evaluates a treatment approach called induction radiochemotherapy that uses low doses of ionizing radiation combined with chemotherapy medications. The chemotherapy drugs used in this study are paclitaxel and carboplatin, which are given through an intravenous injection directly into the bloodstream.

The purpose of this research is to determine how effective and well-tolerated this combined treatment approach is for patients with advanced throat and larynx cancer. The treatment involves receiving both chemotherapy medications along with low-dose radiation therapy. During the study, patients will receive treatment over a period of up to 37 days.

The study will monitor how patients respond to the treatment by examining the cancer’s response, checking for any spread of the disease, and tracking overall patient survival. The research will also look at how low doses of radiation affect the body at both molecular and biochemical levels. Throughout the treatment period, doctors will carefully watch for and record any side effects that patients may experience.

]]>